ASCEND BY NTHRYS
Research Abroad Products

Genomics Project Topics

Browse all focused areas across all project categories under this field.

Showing 1945–1956 of 2250 project topics
Rare Tumor Variant Interpretation SaaS Platform
A cloud-based software platform that automatically annotates, prioritizes, and classifies pathogenic variants in rare tumor genomes using proprietary machine learning models and clinical databases. Enables labs to accelerate molecular diagnosis turnaround time and unlock recurring subscription revenue through tiered licensing models.
Genomics of Rare Tumors Click to view more details →
Liquid Biopsy ctDNA Detection Kit Commercial Launch
A diagnostic kit product that captures and sequences circulating tumor DNA from blood samples to detect rare tumor mutations with ultra-high sensitivity for early screening and monitoring. Creates a high-margin consumables business with recurring testing demand across oncology centers and personalized medicine clinics.
Genomics of Rare Tumors Click to view more details →
Rare Cancer Genomic Data Intelligence Analytics Suite
An advanced analytics platform that aggregates and visualizes genomic, clinical, and outcome data from rare tumor patients to identify novel therapeutic targets and biomarkers. Generates revenue through enterprise licensing to pharmaceutical companies and contract research organizations seeking rare disease drug development insights.
Genomics of Rare Tumors Click to view more details →
Multi-Cancer Panel Testing Service Marketplace Platform
A B2B2C marketplace platform connecting healthcare providers with certified laboratories offering comprehensive genomic panels specifically optimized for rare tumor diagnosis and treatment selection. Captures transaction fees and builds a scalable network effect business by aggregating supply, demand, and clinical outcomes data across oncology ecosystems.
Genomics of Rare Tumors Click to view more details →
AI-Powered Rare Tumor Classification Diagnostic Engine
A deep learning diagnostic tool that classifies histologically ambiguous rare tumors using integrated genomic, transcriptomic, and imaging data to enable definitive molecular diagnosis within 48 hours. Monetizes through per-sample analysis fees, clinical laboratory partnerships, and licensing to hospital pathology departments seeking competitive diagnostic differentiation.
Genomics of Rare Tumors Click to view more details →
Rare Tumor Genomic Reference Database Commercial License
A curated, continuously updated genomic database containing annotated variants, copy number alterations, and fusion genes specific to rare tumors with clinical outcomes and treatment response data. Establishes recurring revenue through institutional subscriptions, API licensing to diagnostic platforms, and white-label integration for healthcare technology companies.
Genomics of Rare Tumors Click to view more details →
Slide-Seq and HDST High-Resolution Spatial Transcriptomics
Processing high-density spatial transcriptomics data from Slide-seq and HDST for near-single-cell resolution gene expression mapping.
Single Cell Spatial Omics Click to view more details →
seqFISH Plus for Multiplexed Single Cell Spatial Analysis
Analyzing seqFISH+ data for simultaneous measurement of thousands of genes in single cells with spatial coordinates.
Single Cell Spatial Omics Click to view more details →
Spatial Proteomics by Imaging Mass Cytometry
Processing IMC data for simultaneous spatial protein measurement enabling tissue architecture characterization at single cell resolution.
Single Cell Spatial Omics Click to view more details →
Integration of Spatial and Single Cell Data
Combining spatial transcriptomics with scRNA-seq reference data using RCTD and Tangram for cell type mapping in tissue context.
Single Cell Spatial Omics Click to view more details →
In Situ Hybridization Automation Platforms for High-Throughput
Commercial automation systems that streamline fluorescence in situ hybridization (FISH) workflows for detecting multiple RNA targets simultaneously in tissue samples at scale. These platforms reduce manual labor costs by 60-70% while enabling labs to process hundreds of samples monthly, creating recurring service revenue through consumables and maintenance contracts.
Single Cell Spatial Omics Click to view more details →
Commercial Spatial Transcriptomics SaaS Data Analysis Platform
Cloud-based software platforms that process and visualize spatial transcriptomics data from multiple technology platforms with integrated machine learning pipelines for cell type identification and tissue architecture mapping. These platforms generate subscription revenue from pharmaceutical and biotech companies conducting drug discovery and companion diagnostics at $50K-500K annually per client.
Single Cell Spatial Omics Click to view more details →